Cockayne Syndrome B protein antagonizes OGG1 in modulating CAG repeat length in vivo
2011

CSB Protein's Role in CAG Repeat Length Regulation

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Irina V. Kovtun, Kurt O. Johnson, Cynthia T. McMurray

Primary Institution: Mayo Clinic and Foundation

Hypothesis

Does the Cockayne Syndrome B (CSB) protein influence CAG repeat length in Huntington's disease models?

Conclusion

CSB protects CAG repeats from expansion during parent-child transmission and antagonizes the action of OGG1 in somatic cells.

Supporting Evidence

  • CSB promotes reduction of CAG tract size during transmission in vivo.
  • CSB(−/−) animals showed a 5-fold increase in expansion compared to R6/1 counterparts.
  • CSB antagonizes the effects of OGG1 in vivo.

Takeaway

The CSB protein helps keep certain DNA sequences from getting too long, which can cause diseases like Huntington's.

Methodology

Mice lacking CSB and OGG1 were crossed with HD transgenic mice to analyze changes in CAG tract length.

Limitations

The study primarily focuses on specific mouse models, which may not fully represent human conditions.

Participant Demographics

Mice used in the study included transgenic and knockout strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication